IBRX Stock Analysis: Buy, Sell, or Hold?
IBRX - ImmunityBio, Inc. Common Stock
$6.25
0.34 (5.75%)
▲
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 02, 2026
28d
Get Alerted When IBRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
79 traders called IBRX this week
97% bullish • 4 bearish
97% bullish • 4 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: IBRX is 7.8% above fair value ($5.80). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: IBRX is 7.8% above fair value ($5.80). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: IBRX is currently trading at $6.25, which is considered extended relative to its 30-day fair value range of $1.85 to $5.80.
Technical Outlook: Technically, IBRX is in a downtrend. Immediate support is located at $4.38, while resistance sits at $8.28. The stock is showing strong short-term momentum, up 5.8% recently.
Market Sentiment: IBRX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.80 (+88.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IBRX is in a downtrend. Immediate support is located at $4.38, while resistance sits at $8.28. The stock is showing strong short-term momentum, up 5.8% recently.
Market Sentiment: IBRX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.80 (+88.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$1.85 -
$5.80
Company Quality Score
55/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
57.9%
Protect Your Profits
IBRX is technically overbought (RSI 71). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+7.8% above fair value)
- BULLISH: Strong technical setup (75/100)
- BULLISH: Strong upward momentum (+5.8%)
- BULLISH: Trading 88.8% below Wall St target ($11.80)
Fair Price Analysis
30-Day Fair Range
$1.85 -
$5.80
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$4.38
Resistance Level
$8.28
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-24.35
Wall Street Target
$11.80
(+88.8%)
Revenue Growth (YoY)
425.1%
Last updated: February 01, 2026 4:33 PM ET
Data refreshes hourly during market hours. Next update: 5:33 PM
Data refreshes hourly during market hours. Next update: 5:33 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IBRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 63 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$56 | 59 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 62 BUY |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
Advanced IBRX Option Strategies
Professional options setups generated by AI based on today's IBRX price and gamma walls.
